Skip to main content
Advertisement
  • Loading metrics

A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants

  • Bambang S. Adiwijaya ,

    bambang_adiwijaya@vrtx.com

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  • Eva Herrmann,

    Affiliation Institute of Biostatistics and Mathematical Modeling, Faculty of Medicine, Johann Wolfgang Goethe University, Frankfurt am Main, Germany

  • Brian Hare,

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  • Tara Kieffer,

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  • Chao Lin,

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  • Ann D. Kwong,

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  • Varun Garg,

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  • John C. R. Randle,

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  • Christoph Sarrazin,

    Affiliation Medizinische Klinik 1, J. W. Goethe-University Hospital, Frankfurt am Main, Germany

  • Stefan Zeuzem,

    Affiliation Medizinische Klinik 1, J. W. Goethe-University Hospital, Frankfurt am Main, Germany

  • Paul R. Caron

    Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.